Literature DB >> 2166440

VIP-induced alterations in cAMP and inositol phosphates in the lower esophageal sphincter.

S M Szewczak1, J Behar, G Billett, C Hillemeier, B Y Rhim, P Biancani.   

Abstract

Adenosine 3',5'-cyclic monophosphate (cAMP), guanosine 3',5'-cyclic monophosphate (cGMP), and inositol phosphate (IP) levels were measured in thin tissue samples from the circular smooth muscle of the cat lower esophageal sphincter (LES) at 37 degrees C during vasoactive intestinal peptide (VIP)-induced relaxation. On exposure of in vitro LES circular muscle strips to 10(-6) M VIP at the same temperature, relaxation of spontaneous resting tone begins within 3-6 s, is half maximal at 30 s, and maximal at 1 min. VIP-induced changes in cAMP, cGMP, and IP metabolite levels were measured at 5 and 30 s after the addition of 10(-6) M VIP. At 5 s cAMP levels increased significantly with respect to time-matched unstimulated controls, whereas inositol 1,4,5-trisphosphate (1,4,5-IP3) decreased and these changes remained constant at 30 s. cGMP levels were unchanged at either 5 or 30 s after exposure to 10(-6) M VIP. These data suggest that VIP-induced relaxation is temporally linked to decreased 1,4,5-IP3 as well as increased cAMP levels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166440     DOI: 10.1152/ajpgi.1990.259.2.G239

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Regulation of smooth muscle delayed rectifier K+ channels by protein kinase A.

Authors:  S D Koh; K M Sanders; A Carl
Journal:  Pflugers Arch       Date:  1996-07       Impact factor: 3.657

Review 2.  Regulation of basal tone, relaxation and contraction of the lower oesophageal sphincter. Relevance to drug discovery for oesophageal disorders.

Authors:  R Farré; D Sifrim
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

3.  Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter.

Authors:  L Ny; B Larsson; P Alm; P Ekström; J Fahrenkrug; J Hannibal; K E Andersson
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.